Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Bouvry, J. M. Naccache, P. Y. Brillet, V. Cottin, J. Schmidt, J. Haroche, J. P. Ducroix, J. F. Viallard, R. Lazor, A. Tazi, B. Wallaert, F. Lebargy, J. F. Cordier, L. Mouthon, D. Valeyre (Bobigny, Bron, Amiens, Paris, Pessac, Berne, Lille, Reims, France). Interstitial lung disease in common variable immunodeficiency associated granulomatous disease. Eur Respir J 2009; 34: Suppl. 53, 3140

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary diseases in primary immunodeficiency syndromes Source: Respipedia Article Year: 2017 Interstitial lung disease associated with polymyositis-dermatomyositis Source: Eur Respir J 2005; 26: Suppl. 49, 31s Year: 2005 A case of lymphoid interstitial pneumonia associated with common variable immunodeficiency Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Source: Eur Respir J 2011; 38: 384-391 Year: 2011 Prevalence of progressive fibrosing interstitial lung disease Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Metabolic syndrome in interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 Rituximab in severe, progressive interstitial lung disease Source: International Congress 2016 – Connective tissue disorders Year: 2016 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Interstitial lung disease associated with autoimmune thyroiditis (ILD-AT) Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Lymphocytic interstitial pneumonia – a rare underestimated entity of interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 257s Year: 2007 Idiopathic interstitial pneumonia and connective tissue disorder-related interstitial lung disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=170 Year: 2007 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis Source: Eur Respir J 2013; 41: 115-122 Year: 2013 Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010